WO2003000402A1 - Process for producing heat-expandable microcapsule - Google Patents
Process for producing heat-expandable microcapsule Download PDFInfo
- Publication number
- WO2003000402A1 WO2003000402A1 PCT/JP2002/006209 JP0206209W WO03000402A1 WO 2003000402 A1 WO2003000402 A1 WO 2003000402A1 JP 0206209 W JP0206209 W JP 0206209W WO 03000402 A1 WO03000402 A1 WO 03000402A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- microcapsules
- heat
- monomer component
- polymer
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
Definitions
- the present invention relates to a method for producing a heat-expandable microcapsule, particularly a heat-expandable microcapsule having excellent heat resistance and solvent resistance.
- BACKGROUND ART A method for producing a heat-expandable microcapsule by using a thermoplastic polymer as a wall material and microencapsulating a volatile expanding agent that becomes gaseous at a temperature lower than the softening point of the polymer is known.
- Japanese Patent Publication No. 42-26524 discloses that a liquid foaming agent such as a low-boiling aliphatic hydrocarbon is added to a monomer, and an oil-soluble polymerization initiator is mixed with the monomer component.
- a liquid foaming agent such as a low-boiling aliphatic hydrocarbon
- an oil-soluble polymerization initiator is mixed with the monomer component.
- the heat-expandable microcapsule obtained by the production method disclosed in the above publication is not excellent in heat resistance and solvent resistance, and expands and expands at a low temperature of about 80 to 130 ° C, There was a problem that the foaming ratio was reduced under heating conditions of high temperature and long time.
- a heat-expandable microcapsule for converting a volatile expander which becomes gaseous at a temperature equal to or lower than the softening point of the polymer into a micro force Using a polymer obtained from a monomer component containing 0.1 to 1% by weight, a heat-expandable microcapsule for converting a volatile expander which becomes gaseous at a temperature equal to or lower than the softening point of the polymer into a micro force.
- the heat-expandable microcapsules obtained by this manufacturing method are superior in heat resistance to the heat-expandable microcapsules obtained by the conventional manufacturing method. Is also excellent.
- microcapsules are liable to shrink or break when heated at high temperatures for long periods of time. There is a problem that the stability at the time of foaming is insufficient. Summary of the Invention
- An object of the present invention is to provide a combination of excellent heat resistance and excellent solvent resistance, hardly cause shrinkage and bubble breakage even under high temperature and long-time heating conditions, and excellent heat expansion stability (foaming stability).
- An object of the present invention is to provide an efficient and simple method for producing expandable microcapsules.
- the present invention acrylonitrile 5 for 5-7 5 weight 0/0, methacrylonitrile 2 0-4 0 wt%, vinyl acetate 1-1 0% by weight and tetrafunctional or more crosslinking agents from 0.1 to 1 weight
- a volatile expander which becomes gaseous at a temperature lower than the softening point of the polymer obtained from the monomer component, is polymerized under nitrogen pressure to form a microcapsule. It is a manufacturing method of a capsule.
- the monomer component used in the method for producing a heat-expandable microcapsule of the present invention contains 55 to 75% by weight of acrylonitrile and 20 to 40% by weight of methacrylic nitrile as nitrile monomers.
- heat-expandable microcapsules hereinafter also referred to as microcapsules.
- the solvent resistance becomes insufficient, and conversely, the content of acrylonitrile in the monomer component exceeds 75% by weight and / or the content of methacrylonitrile becomes 40% by weight. If it exceeds, the glass transition temperature of the microcapsules becomes too high, and the thermal expansion (foamability) is impaired.
- the monomer component used in the method for producing a thermally expandable microcapsule of the present invention contains 1 to 10% by weight of vinyl acetate as a non-nitrile monomer.
- vinyl acetate as a non-nitrile monomer.
- the content of vinyl acetate in the monomer component is less than 1% by weight, it is not possible to sufficiently promote the growth radical reactivity of metathalonitrile, and conversely, the content of vinyl acetate in the monomer component is reduced. If it exceeds 10% by weight, the glass transition temperature of the polymer becomes too low, and the heat resistance and the solvent resistance of the microcapsule become insufficient.
- the monomer component used in the method for producing a heat-expandable micro force cell of the present invention contains 0.1 to 1% by weight of a crosslinking agent having four or more functional groups as a crosslinking agent.
- a crosslinking agent having four or more functional groups in the monomer component, the degree of crosslinking of the polymer obtained from the mixed monomer comprising acrylonitrile, methacrylic acid-tolyl, and butyl acetate can be sufficiently increased.
- the microcapsules are less likely to shrink or break even under high temperature and long heating conditions.
- crosslinker having four or more functionalities examples include, for example, pentaerythritol tetraacrylate, pentaerythritol tetramethacrylate, dipentaerythritol hexaatalylate, and dipentaerythritol hexamethacrylate, which are preferably used. These crosslinkers having four or more functionalities may be used alone or in combination of two or more.
- the content of the cross-linking agent having four or more functionalities in the monomer component is less than 0.1% by weight, the degree of cross-linking of the polymer is not sufficiently improved, and conversely, the cross-linking agent having four or more functionalities in the monomer component is Even if the content exceeds 1% by weight, the degree of crosslinking of the polymer is no longer improved.
- the monomer component used in the manufacturing method of the heat-expandable micro power capsule of the present invention may optionally within a range that does not inhibit the assignment achievement of the present invention, for example, alpha-Kuroruakuri Ronitorinore, alpha - ethoxyacrylonitrile, such Fumaronitorinore Nitrile monomers other than acrylonitrile and methacrylonitrile, acrylates such as methyl acrylate, ethyl acrylate, butyl acrylate, dicyclopentenyl acrylate, etc., methyl methacrylate, ethyl methacrylate, and butyrate methacrylate.
- alpha-Kuroruakuri Ronitorinore alpha - ethoxyacrylonitrile
- Fumaronitorinore Nitrile monomers other than acrylonitrile and methacrylonitrile such as methyl acrylate, ethyl acrylate, butyl acrylate, dicyclopentenyl
- Methacrylates such as isobonyl methacrylate, and vinyl acetate such as styrene. And a non-nitrile-based monomer other than toluene.
- nitrile-based monomers other than atarilonitrile and methacrylonitrile and non- nitrile-based monomers other than butyl acetate may be used alone or in combination of two or more.
- the wall material of the microcapsule produced by the method for producing a thermally expandable microcapsule of the present invention comprises a monomer component comprising the above-mentioned acrylonitrile, methacrylonitrile, biel acetate, and a tetrafunctional or more cross-linking agent; It is prepared by blending as appropriate.
- polymerization initiator examples include various known polymerization initiators generally used in this field, and are preferably used. Among them, oil-soluble polymerization initiators soluble in acrylonitrile, methacrylonitrile and vinyl acetate are preferred. Agents are particularly preferably used. Examples of the oil-soluble polymerization initiator include dialkyl peroxide, diacyl peroxide, peroxyester, peroxydicarbonate, and azo compound.
- dialkyl peroxides such as methylethyl peroxide, di-tert-butyl peroxide, and dicumyl peroxide; isoptyl peroxide, benzoin peroxide , 2,4-diclo-benzoylperoxide, 3,5,5-dimethyl peroxide such as trimethylhexanoyl peroxide; t-butyl benzoyl oxyvalate, t-hexyl oxy valiva, t-Butyl peroxy sineodecanoate, t-hexyloxy neodecanoate, 1-cyclohexyl-1- 1-methylethyl peroxy neodecanoate, 1,1,3,3-tetramethyl Peroxyesters such as butyl peroxy neodecanoate, cumyl peroxy neodecanoate, ( ⁇ , ⁇ -bis-neodecanyl baroxy) diisopropylbenzene Bis
- the volatile swelling agent used in the method for producing a thermally expandable microcapsule of the present invention and contained in the microcapsule is a substance which becomes gaseous at a temperature equal to or lower than the softening point of the polymer obtained from the monomer component. If the volatile expanding agent is a substance which becomes gaseous at a temperature exceeding the softening point of the polymer, the microcapsules tend to contract or break during thermal expansion (foaming).
- volatile swelling agent examples include a low-boiling organic solvent and a compound which is thermally decomposed by heating and becomes gaseous, and is preferably used. Among them, a low-boiling organic solvent is particularly preferably used. . These volatile swelling agents may be used alone or in combination of two or more.
- low-boiling organic solvent examples include ethane, ethylene, propane, propylene, n-butane, isobutane, n-butene, isobutene, n-pentane, isopentan, neopentane, n-hexane, heptane, petroleum Low-molecular-weight carbon such as ether; hydrogen such as CC13F, CC12F2, CC1F3, CC1F2-CC12F2; and chlorofluorocarbon such as CC12F2; tetramethylenosilane, trimethylethyl Examples thereof include tetraalkylsilanes such as silane, trimethylisopropyl silane, and trimethyl_n-propyl silane, which are preferably used.
- n-butane, isobutane, n-pentane, isopentane, n-hexane and Petroleum ether is particularly preferably used.
- These low-boiling organic solvents may be used alone or in combination of two or more.
- the monomer component and the volatile expander are polymerized under nitrogen pressure to form a microcapsule.
- the pressure value at the time of pressurizing the nitrogen is not particularly limited, but is preferably 0.1 to 2.0 MPa. If the pressure value at the time of pressurizing nitrogen is less than 0. IMP a, the radical reactivity of atarilonitrile / methacrylonitrile will deteriorate and the bulk specific gravity will decrease. Microcapsules with low bulk density may have poor thermal expansion stability (foaming stability) under high temperature and long-time heating conditions, causing shrinkage and foam breakage.
- the method of polymerizing the monomer component and the volatile swelling agent under nitrogen pressure of preferably 0.1 to 2.0 OMPa to microencapsulate is not particularly limited. good. A particularly preferred method is described in, for example,
- a monomer component is mixed with a volatile swelling agent and a polymerization initiator, and the mixture is mixed in an aqueous dispersion medium containing an appropriate dispersion stabilizer, co-stabilizer and the like. This is a suspension polymerization method.
- the suspension polymerization is usually carried out in an aqueous dispersion medium containing a dispersion stabilizer, an auxiliary stabilizer and the like.
- dispersion stabilizer examples include silica such as colloidal silica, calcium phosphate, magnesium hydroxide, aluminum hydroxide, ferric hydroxide, barium sulfate, calcium sulfate, sodium sulfate, calcium oxalate, calcium carbonate, and the like. It includes potassium carbonate, magnesium carbonate and the like, and is preferably used. These dispersion stabilizers may be used alone or in combination of two or more. The amount of the dispersion stabilizer used is not particularly limited, but is preferably 0.1 to 20 parts by weight based on 100 parts by weight of the monomer component.
- co-stabilizer examples include condensation products such as condensation products of diethanolamine and aliphatic dicarbonic acid and condensation products of urea and formaldehyde; polybutylpyrrolidone and polyethyleneimine; A water-soluble nitrogen-containing compound of the following; polyethylene oxide, tetramethylammonium hydroxide, gelatin, methyl alcohol, polyvinyl alcohol, octyl sulfosuccinate, sorbitan ester, various emulsifiers, and the like. Used for These co-stabilizers may be used alone or in combination of two or more.
- the aqueous dispersion medium used for the suspension polymerization is prepared by blending the above-mentioned dispersion stabilizer and auxiliary stabilizer in deionized water.
- the pH of the aqueous phase during suspension polymerization is used It is appropriately determined depending on the type of the dispersion stabilizer, the auxiliary stabilizer and the like. For example, when silica such as colloidal silica is used as the dispersion stabilizer, suspension polymerization is performed in an acidic aqueous phase. To make the aqueous phase acidic, the pH of the aqueous phase may be adjusted to 3 to 6 by adding an acid such as hydrochloric acid as needed.
- suspension polymerization is performed in an alkaline aqueous phase.
- the pH of the aqueous phase may be adjusted to 8 to 11 by adding a base such as caustic soda as needed.
- An example of a preferred combination of the dispersion stabilizer and the co-stabilizer includes a combination of colloidal silica (dispersion stabilizer) and a condensation product (co-stabilizer).
- a condensation product of diethanolamine and an aliphatic dicarboxylic acid is preferable, and among them, a condensation product of diethanolamine and adipic acid and a condensation product of diethanolamine and itaconic acid are preferable. Particularly preferred.
- These condensation products may be used alone or in combination of two or more. Further, when an inorganic salt such as sodium chloride / sodium sulfate is added, microcapsules having a more uniform particle shape can be easily obtained.
- the amount of the above-mentioned colloidal silica may be adjusted depending on the particle size, and is not particularly limited.However, it may be 1 to 20 parts by weight of the colloidal silica with respect to 100 parts by weight of the monomer component. Preferably, it is more preferably 2 to 10 parts by weight.
- the amount of the condensation product used may be adjusted depending on the kind thereof, and is not particularly limited. However, the amount of the condensation product is 0.0 with respect to 100 parts by weight of the monomer component.
- the amount of the inorganic salt to be used may be adjusted depending on the type thereof, and is not particularly limited. However, the amount of the inorganic salt is 100 parts by weight or less based on 100 parts by weight of the monomer component. Is preferred.
- Another example of a preferable combination of the dispersion stabilizer and the co-stabilizer is a combination of colloidal silica (dispersion stabilizer) and a water-soluble nitrogen-containing compound (co-stabilizer).
- the water-soluble nitrogen-containing compound include polybutylpyrrolidone, polyethyleneimine, polyoxyethylenealkylamine, polydimethylaminoethyl acrylate, and polydialkylaminoalkyl represented by polydimethylaminoethyl methacrylate.
- polydimethyla Minopropylacrylamide polydialkylaminoalkyl (meth) acrylamide represented by polydimethylaminopropylmethacrylamide, polyatarylamide, polycationic acrylamide, polyaminesulfone, polyallylamine, etc.
- polyvinylpyrrolidone is particularly preferably used.
- These water-soluble nitrogen-containing compounds may be used alone or in combination of two or more.
- the amount of colloidal silica used is preferably fixed to 1 to 20 parts by weight of colloidal silica with respect to 100 parts by weight of the monomer component, and It is preferable to adjust by changing the amount of don used.
- the combination of the dispersion stabilizer and the co-stabilizer includes a combination of calcium phosphate or magnesium hydroxide (dispersion stabilizer) with an emulsifier (co-stabilizer).
- each component in the aqueous dispersion medium is arbitrary and not particularly limited.However, usually, deionized water, a dispersion stabilizer and, if necessary, an auxiliary stabilizer are charged into a polymerization vessel, and the dispersion is stabilized. An aqueous dispersion medium containing the agent is prepared. If necessary, compounds such as alkali metal nitrite, stannous chloride, stannic chloride and potassium dichromate are added. The monomer component and the volatile swelling agent may be individually added to an aqueous dispersion medium to form an oily mixture in the aqueous dispersion medium. Prepare and add the oily mixture to the aqueous dispersion medium.
- the polymerization initiator may be added to the oily mixture in advance, or may be added after stirring and mixing the aqueous dispersion medium and the oily mixture in a polymerization vessel.
- the aqueous dispersion medium and the oily mixture may be mixed in a separate container in advance and mixed by stirring, and then charged into the polymerization vessel.
- the particle diameter of the microcapsules obtained by the method for producing thermally expandable microcapsules of the present invention is not particularly limited, but is about 5 to 50 / zm in a state before thermal expansion (unfoamed state). Preferably, there is.
- the amount of the volatile swelling agent included in the microcapsules is not particularly limited, but is preferably about 10 to 20% by weight. According to the method for producing a heat-expandable microcapsule of the present invention, the amount ratio of acrylonitrile, methacrylonitrile, butyl acetate, and a tetrafunctional or higher crosslinking agent constituting the monomer component is controlled within the above-described specific amounts.
- Various types of microcapsules exhibiting thermal expansion behavior (foaming behavior) according to the intended use can be manufactured by selecting the type of volatile expanding agent.
- the microcapsule produced by the method for producing a heat-expandable microcapsule of the present invention is a polymer obtained from a monomer component containing acrylonitrile, methacrylonitrile, vinyl acetate and a specific amount of a tetrafunctional or higher crosslinker.
- the wall material is composed of a volatile expander which becomes gaseous at a temperature lower than the softening point of the polymer, and has excellent heat resistance and excellent solvent resistance. Shrinkage and foam breakage are unlikely to occur even under heating conditions, and the expansion ratio does not decrease.
- Example 2 The oil-based mixtures were each prepared with the composition shown in Table 1, and the average particle diameter was 20 ⁇ in the same manner as in Example 1 except that the aqueous dispersion medium prepared in Example 1 was used as the aqueous dispersion medium. (Example 2) and 2 / im (Example 3) microcapsules were produced.
- Each of the oily mixtures was prepared with the composition shown in Table 1, and the average particle size was 30 / X by the same method as in Example 1 except that the aqueous dispersion medium prepared in Example 1 was used as the aqueous dispersion medium.
- m Comparative Example 1
- 25 ⁇ m Comparative Example 2 microcapsules were produced.
- the expansion ratio of the microcapsules obtained in Examples 1 to 3 and Comparative Example 2 was measured by the following method.
- Microcapsules and 0 g were placed in a gear oven and heated under the following heating conditions to foam. Next, each of the obtained foams was placed in a measuring cylinder, the volume after foaming was measured, and the foamed volume was divided by the volume when not foamed to obtain a foaming ratio (times). Heating temperature: 140 ° C, 160 ° C, 170 ° C and 180 ° C
- Heating time 1 minute, 2 minutes, 3 minutes and 4 minutes at each of the above heating temperatures ⁇ atrial from 1 frfe
- microcapsules of Comparative Example 2 in which the content of the butyl acetate in the monomer component exceeded 10% by weight had poor heat resistance, and started thermal expansion (foaming) even at 140 ° C. Moreover, at a heating temperature of 160 ° C. or more, shrinkage and foam breakage occurred, and a good foam could not be obtained.
- ADVANTAGE OF THE INVENTION According to this invention, it has excellent heat resistance and excellent solvent resistance, and it is hard to shrink or break even under high-temperature and long-time heating conditions, and has excellent thermal expansion stability (foaming stability).
- An efficient and simple method for producing an inflatable microphone-mouth capsule can be provided.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-188239 | 2001-06-21 | ||
JP2001188239A JP2003001099A (en) | 2001-06-21 | 2001-06-21 | Method of manufacturing thermally expandable microcapsule |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003000402A1 true WO2003000402A1 (en) | 2003-01-03 |
Family
ID=19027377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/006209 WO2003000402A1 (en) | 2001-06-21 | 2002-06-21 | Process for producing heat-expandable microcapsule |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2003001099A (en) |
WO (1) | WO2003000402A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110058095A (en) | 2009-11-25 | 2011-06-01 | 제일모직주식회사 | Heat-expandable microparticles having good expandability and even particle diameter |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3615972A (en) * | 1967-04-28 | 1971-10-26 | Dow Chemical Co | Expansible thermoplastic polymer particles containing volatile fluid foaming agent and method of foaming the same |
JPS62286534A (en) * | 1986-06-04 | 1987-12-12 | Matsumoto Yushi Seiyaku Kk | Manufacture of thermal expansion microcapsule |
EP0566367A2 (en) * | 1992-04-15 | 1993-10-20 | Matsumoto Yushi-Seiyaku Co., Ltd. | Thermoexpandable microcapsules, process for production thereof, and microballoons made therefrom |
EP1054034A1 (en) * | 1998-01-26 | 2000-11-22 | Kureha Kagaku Kogyo Kabushiki Kaisha | Expandable microspheres and process for producing the same |
WO2001083636A1 (en) * | 2000-04-28 | 2001-11-08 | Kureha Kagaku Kogyo K.K. | Heat-expandable macrosphere and process for producing the same |
-
2001
- 2001-06-21 JP JP2001188239A patent/JP2003001099A/en not_active Withdrawn
-
2002
- 2002-06-21 WO PCT/JP2002/006209 patent/WO2003000402A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3615972A (en) * | 1967-04-28 | 1971-10-26 | Dow Chemical Co | Expansible thermoplastic polymer particles containing volatile fluid foaming agent and method of foaming the same |
JPS62286534A (en) * | 1986-06-04 | 1987-12-12 | Matsumoto Yushi Seiyaku Kk | Manufacture of thermal expansion microcapsule |
EP0566367A2 (en) * | 1992-04-15 | 1993-10-20 | Matsumoto Yushi-Seiyaku Co., Ltd. | Thermoexpandable microcapsules, process for production thereof, and microballoons made therefrom |
EP1054034A1 (en) * | 1998-01-26 | 2000-11-22 | Kureha Kagaku Kogyo Kabushiki Kaisha | Expandable microspheres and process for producing the same |
WO2001083636A1 (en) * | 2000-04-28 | 2001-11-08 | Kureha Kagaku Kogyo K.K. | Heat-expandable macrosphere and process for producing the same |
Also Published As
Publication number | Publication date |
---|---|
JP2003001099A (en) | 2003-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0515499B2 (en) | ||
KR101819766B1 (en) | Thermally expandable microcapsule and process for production of thermally expandable microcapsule | |
JPH0919635A (en) | Thermally expandable microcapsule excellent in heat and solvent resistance | |
US6617363B2 (en) | Method of producing thermally expansive microcapsule | |
JPH11209504A (en) | Production of expandable microsphere | |
JP2016172820A (en) | Production method of expandable microsphere, and expandable microsphere | |
JP5991851B2 (en) | Thermally expandable microcapsules | |
JP2005232274A (en) | Thermally expandable microcapsule of high heat resistance and method for producing the same | |
JP4189155B2 (en) | Method for producing thermally expandable microcapsules | |
JP4027100B2 (en) | Method for producing thermally expandable microcapsules | |
JP5727184B2 (en) | Thermally expandable microcapsule, resin composition and foamed sheet | |
WO2003000402A1 (en) | Process for producing heat-expandable microcapsule | |
JP2003001098A (en) | Method of manufacturing thermally expandable microcapsule | |
JP2010229341A (en) | Thermally expandable microcapsule and method for manufacturing the same | |
JP2005103469A (en) | Method of manufacturing heat-expansible microcapsule | |
JP2012131867A (en) | Thermally expandable microcapsule, resin composition and foamed sheet | |
JP4575023B2 (en) | Thermally expandable microcapsule and method for producing the same | |
JP2011074282A (en) | Thermally expandable microcapsule | |
JP2005162996A (en) | Thermally expandable microcapsule | |
JP2004155999A (en) | Thermally expandable microcapsule | |
JP2004105858A (en) | Thermally expandable microcapsule | |
JP2011168749A (en) | Method of manufacturing thermally expansible microcapsule | |
JP2004168790A (en) | Thermally expandable microcapsule | |
JP5839789B2 (en) | Method for producing thermally expandable microcapsules | |
JP6225227B2 (en) | Thermally expandable microcapsules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2004102693 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2004103475 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |